On March 18, 2024, Bristol-Myers Squibb Company announced that it has received a shareholder proposal from Kenneth Steiner, requesting the Company board of directors to adopt an enduring policy, and amend the governing documents as necessary in order that 2 separate people hold the office of the Chairman and the office of the CEO. In addition, the Company urged the shareholders to vote against the shareholder proposal at its annual general meeting of shareholders scheduled to be held on May 7, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.04 USD | +0.32% | +0.23% | -14.17% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.17% | 89.27B | |
+33.43% | 700B | |
+26.43% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+14.32% | 236B | |
+5.79% | 202B | |
-9.49% | 197B | |
+4.26% | 161B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol-Myers Squibb Receives a Shareholder Proposal from Kenneth Steiner